Supratentorial meningioma is a tumor that starts in the lining around the upper part of the brain. It is often slow growing and noncancerous, but it can still press on brain tissue and cause problems. The early symptoms of supratentorial meningioma may include headaches, seizures, weakness, changes in vision or speech, or problems with memory and behavior. It usually affects adults, often later in life, and symptoms can build over months or years; not everyone will have the same experience. Supratentorial meningioma is often treated with regular MRI scans, surgery, or radiation, and while many people do well, serious illness or death can happen if the tumor is large, aggressive, or in a sensitive area of the brain.
How many people live with Supratentorial meningioma?
Worldwide, there is no one widely used count of how many people are living with supratentorial meningioma. In the United States, about 170,000 people are estimated to be living with meningioma overall (American Brain Tumor Association, 2023); because about 80% to 90% of these tumors are in the upper part of the brain, this suggests roughly 136,000 to 153,000 people in the U.S. may be living with supratentorial meningioma, but this is an estimate rather than a direct count.
Overview
Supratentorial meningiomaSymptoms
Supratentorial meningioma may cause headaches, seizures, weakness, vision changes, or trouble with speech or thinking. Symptoms depend on where it presses in the brain. Some people have no symptoms at first.
Outlook and prognosis
For many with supratentorial meningioma, outlook is often good, especially when the tumor is slow-growing and can be fully removed. Prognosis depends on tumor grade, size, location, and whether it comes back after treatment.
Causes and risk factors
Supratentorial meningioma often has no clear cause. Risk rises with older age, female sex and hormone exposure, prior head radiation, inherited gene changes such as NF2, and obesity; most are not linked to anything you did.
Genetic influences
Genetics usually play a limited role in supratentorial meningioma, and most cases are not clearly inherited. Some genetic changes in the tumor itself can affect growth and recurrence risk, while inherited risk is mainly linked to rare conditions such as NF2.
Diagnosis
Supratentorial meningioma is usually diagnosed with a neurological exam and brain imaging, especially MRI; CT may also help. A tissue sample after surgery or biopsy can confirm the diagnosis of supratentorial meningioma.
Treatment and drugs
Supratentorial meningioma is often treated with surgery when it can be removed safely. Some people also need focused radiation, and medicines such as steroids or anti-seizure drugs can help with swelling, headaches, or seizures.
Symptoms
Many people with supratentorial meningioma feel well at first, then start noticing changes that interrupt ordinary routines, like more headaches, a first seizure, or trouble finding words. The symptoms depend mainly on where the tumor is pressing in the upper part of the brain and how much pressure it creates. Symptoms vary from person to person and can change over time. Some tumors are found by chance, but others cause gradual early symptoms of supratentorial meningioma over weeks or months.
Headaches are common and may become more frequent, more intense, or harder to ignore over time. They can be worse in the morning or when coughing, bending, or straining raises pressure inside the head.
A new seizure can be the first sign, even in someone who has never had one before. Some seizures cause shaking and loss of awareness, while others are brief spells of staring, confusion, odd smells, or jerking in one arm or leg.
Pressure on movement or sensation areas can cause weakness, clumsiness, or numbness, often on one side of the body. Simple tasks like typing, fastening buttons, or lifting a shopping bag may suddenly feel less steady.
If the tumor affects language areas, people with supratentorial meningioma may struggle to find words or understand what others are saying. Reading, writing, or following a conversation can take more effort than usual.
How people usually first notice Supratentorial meningioma?
Supratentorial meningioma is often first noticed when slow, persistent changes start to stand out, such as headaches that keep coming back, a new seizure, or trouble with vision, speech, memory, or weakness on one side of the body. Because these tumors grow above the brain’s tent-like covering called the tentorium and often enlarge slowly, many people with supratentorial meningioma first signs may seem subtle at first, like personality changes, increasing clumsiness, or trouble concentrating rather than sudden severe symptoms. In many living with this condition, the tumor is first found after symptoms lead to brain imaging, or sometimes by accident when a scan is done for another reason.
Types of Supratentorial meningioma
Supratentorial meningioma can behave differently depending on where it grows in the upper part of the brain. In practice, the main types of supratentorial meningioma are usually described by location, because location often shapes which symptoms appear first and how noticeable they are in daily life. Symptoms don’t always look the same for everyone. A small tumor may cause few problems at first, while one pressing on nearby brain tissue can lead to headaches, seizures, vision changes, or changes in thinking and behavior.
Convexity
This type grows along the brain’s outer surface under the skull. Many people notice headaches or seizures first, and some develop weakness or numbness if the tumor presses on movement or sensation areas.
Parasagittal
This type forms near the midline of the brain, close to a major draining vein. Symptoms often include leg weakness, walking difficulty, or seizures, and some may have trouble with bladder control if the nearby brain region is affected.
Falcine
Falcine meningiomas grow from the fold of tissue that separates the two halves of the brain. Depending on the exact spot, they can cause weakness on one side, changes in concentration, or seizures.
Sphenoid wing
This type develops near the temple and behind the eye, so symptoms can be quite different from other variants of supratentorial meningioma. People may have vision changes, eye bulging, facial numbness, or headaches if nearby nerves and structures are compressed.
Olfactory groove
This type grows at the base of the front part of the brain, near the smell nerves. Early symptoms of supratentorial meningioma in this area can include reduced sense of smell, personality or behavior changes, and headaches that build slowly over time.
Tuberculum sellae
This type sits near the optic nerves and the pituitary region. Vision loss, blurred vision, or trouble seeing to the sides are common, and headaches may also occur.
Intraventricular
This less common type grows inside the brain’s fluid-filled spaces rather than along the outer covering. Symptoms may stay mild for a while, but larger tumors can block fluid flow and lead to headaches, nausea, balance problems, or changes in alertness.
Can I slow down the onset of symptoms?
Probably not in any proven way: for supratentorial meningioma, a usually slow-growing tumor in the lining over the upper part of the brain, there is no strong evidence that diet, exercise, sleep, or supplements can meaningfully delay when symptoms begin. Research has not found a reliable lifestyle change that prevents these tumors or clearly pushes symptoms back, although avoiding unnecessary radiation to the head is sensible because it is one of the few known risk factors. If a meningioma has already been found, regular follow-up with brain scans may help catch growth early and guide treatment before symptoms become more serious, but it cannot guarantee that symptoms will be delayed or prevented.
What genetics can tell you about symptoms
For supratentorial meningioma, genetics can sometimes give clues about how the tumor may behave, but day-to-day symptoms still depend most on where it sits in the brain and how much pressure it causes. Certain tumor gene changes are linked with tumors that grow in particular areas or act more or less aggressively, which can affect whether problems such as headaches, seizures, weakness, or changes in thinking show up and how severe they become. In a small number of people, inherited conditions such as NF2 can raise the chance of developing meningiomas at a younger age or having more than one tumor, but genetics usually cannot predict the exact symptoms any one person will have.
Causes and risk factors
Many people with supratentorial meningioma want to know why it happened, but there is often no single clear cause. It usually develops when cells in the lining around the brain pick up DNA changes and start growing more than they should. Risk factors for supratentorial meningioma include older age, being female, and past radiation to the head. An inherited condition such as NF2 and a strong family history can raise risk, and obesity may also play a part. Some risks are modifiable (things you can change), others are non-modifiable (things you can’t).
What are the most common causes or risk factors?
For many people living with supratentorial meningioma, the exact cause is not clear. The most established risk factors are older age, being female, past radiation treatment to the head, and rare inherited conditions that run in families, especially neurofibromatosis type 2, which makes these tumors more likely. Obesity may also raise the risk, but many people who develop this tumor do not have any obvious risk factor.
Environmental and biological risk factors
A supratentorial meningioma is a meningioma that grows in the coverings of the upper part of the brain. The clearest risk factors for supratentorial meningioma are older age, female sex, and past ionizing radiation, especially to the head. Being exposed to risks in your body or environment doesn't mean illness is inevitable.
Supratentorial meningioma becomes more common as people get older, especially after middle age. This likely reflects slow cell changes that build up over time in the tissues covering the brain.
Supratentorial meningioma is diagnosed more often in women than in men. Researchers think hormones may influence risk, although the exact reason is still not fully clear.
Previous exposure to ionizing radiation is one of the clearest environmental risk factors for supratentorial meningioma. Risk is highest after radiation treatment to the head or neck, especially in childhood, and the tumor may appear many years later.
Genetic risk factors
Most supratentorial meningiomas develop from DNA changes that happen in the tumor cells themselves, rather than from a change inherited from a parent. Inherited risk is uncommon, but it becomes more important when meningiomas appear at a younger age, when there is more than one tumor, or when close relatives are also affected. Some risk factors are inherited through our genes. Knowing the genetic risk factors for supratentorial meningioma can help families understand when genetic counseling or testing may be worth discussing.
Tumor DNA changes: Most supratentorial meningiomas are caused by gene changes that arise only in the tumor. These changes are not present in the rest of the body and usually are not passed on to children.
NF2 gene: Changes in the NF2 gene are the best-known genetic cause of many supratentorial meningiomas, especially those growing on the brain surface or along the midline covering. If NF2 is changed only in the tumor, it explains the tumor's growth but usually does not mean relatives are at higher risk. Rarely, an inherited NF2-related syndrome can lead to multiple meningiomas.
Other driver genes: Some tumors are driven by changes in genes such as TRAF7, KLF4, AKT1, PIK3CA, SMO, or POLR2A. These are usually tumor-only changes rather than inherited ones. Different gene changes often match with different meningioma subtypes and locations.
Family history: A family history of meningioma is uncommon, but it can sometimes signal an inherited predisposition. Doctors may think more about a genetic cause when several relatives are affected, when tumors appear at a younger age, or when one person has multiple meningiomas. One isolated family case usually does not mean everyone in the family has a high risk.
Inherited syndromes: A small number of people with supratentorial meningioma have an inherited syndrome involving genes such as NF2, SMARCB1, SMARCE1, or BAP1. These syndromes can raise the chance of developing one or more meningiomas and, in some families, other tumors as well.
Lifestyle risk factors
For supratentorial meningioma, lifestyle risk factors are less clearly defined than they are for many other conditions. The strongest lifestyle-related signal in current research is excess body weight, while other factors such as physical inactivity, diet pattern, alcohol use, and smoking have weaker or inconsistent links. When people ask about lifestyle risk factors for supratentorial meningioma, it is important to know that most lifestyle associations appear modest rather than definitive.
Overweight and obesity have been linked in several studies to a higher risk of meningioma, including tumors in supratentorial locations. Hormonal and inflammatory changes related to excess body fat may help create conditions that support tumor growth.
Physical inactivity may indirectly increase risk by promoting weight gain and poorer metabolic health. Regular exercise may be protective mainly because it helps with body-weight regulation and insulin sensitivity.
No single food is a proven cause of supratentorial meningioma, but diets that promote obesity and metabolic dysfunction may contribute indirectly to risk. A balanced eating pattern matters most through its effect on body weight and long-term inflammation.
Alcohol has not shown a strong or consistent association with meningioma risk in most studies. Heavy long-term drinking may still worsen overall brain and metabolic health, so any effect is considered uncertain rather than established.
Risk prevention
For most people, there is no sure way to prevent supratentorial meningioma, because many cases happen without a clear, controllable cause. Prevention is about lowering risk, not eliminating it completely. The most practical steps focus on avoiding known risks, especially unnecessary radiation, and managing health factors that may raise the chance of these tumors. For people with inherited risk or past high-dose radiation exposure, prevention often means closer monitoring rather than true prevention of the tumor itself.
The clearest preventable risk for supratentorial meningioma is unnecessary exposure to ionizing radiation, especially to the head. Imaging tests such as CT scans can be important when needed, but avoiding repeat scans without a good reason may help reduce the risk of supratentorial meningioma over time.
Some meningiomas seem to be influenced by hormones, so it is worth reviewing hormone medicines with your doctor if you have a personal history of meningioma or higher risk. Do not stop birth control, menopause treatment, or other hormone therapy on your own, but ask whether the benefits and risks still fit your situation.
Obesity has been linked to a higher risk of meningioma in some studies, so keeping to a healthy weight may help lower risk. Everyday choices like food, exercise, and stress management are simple forms of prevention.
If many family members have had meningiomas or you have a condition such as neurofibromatosis type 2, your risk may be higher than average. Different people need different prevention strategies—there’s no single formula, and in this setting regular specialist follow-up may matter more than lifestyle changes alone.
Can you prevent Supratentorial meningioma?
There is no sure way to prevent a supratentorial meningioma, which is a tumor that grows in the lining around the upper part of the brain. Most cases happen without a clear cause, so prevention is often not possible. The one risk factor doctors know best is past radiation to the head, so avoiding unnecessary head radiation when possible may help lower risk, but it cannot guarantee prevention.
Transmission
Supratentorial meningioma is not contagious, so it cannot be transferred from one person to another through touch, coughs, sex, blood, or everyday contact. For many living with supratentorial meningioma, this means there is no risk of giving it to family members, coworkers, or children through normal contact.
Most supratentorial meningiomas happen sporadically, meaning they develop by chance in the tissue covering the brain rather than being passed down in families. When people ask about how supratentorial meningioma is inherited, the answer is that inherited cases are uncommon, although a small number are linked to genetic conditions such as neurofibromatosis type 2, which can raise the risk of meningiomas.
When to test your genes
For most people with a supratentorial meningioma, routine inherited gene testing is not needed. It is worth discussing if the tumor appears at a young age, if there are multiple meningiomas, a strong family history, or signs of syndromes such as NF2. After diagnosis, tumor gene testing may sometimes refine prognosis or trial options.
Diagnosis
Supratentorial meningioma is usually found after symptoms or imaging changes lead to a closer medical workup. Because this tumor grows in the upper part of the brain, people may notice headaches, seizures, weakness, or changes in thinking, vision, or personality depending on where it sits. Doctors usually combine the exam, brain scans, and sometimes tissue testing to confirm the diagnosis of supratentorial meningioma. Some diagnoses are clear after a single visit, while others take more time.
Doctors ask about symptoms such as headaches, seizures, vision changes, weakness, or gradual changes in memory and behavior. A detailed family and health history can help show how long symptoms have been developing and whether another condition could be causing them.
The exam checks strength, balance, reflexes, speech, sensation, and vision. These findings can point to which area of the brain may be affected and help guide the next tests.
MRI with contrast is the main imaging test used to look for a supratentorial meningioma. It can show the tumor's size, exact location, pressure on nearby brain tissue, and features that help doctors judge whether it looks typical for a meningioma.
A CT scan may be used if MRI is not available or cannot be done safely. It can also show calcium within the tumor and changes in the nearby skull bone that sometimes occur with meningiomas.
How is Supratentorial meningioma diagnosed?
Supratentorial meningioma is usually suspected when someone has symptoms like headaches, seizures, weakness, or changes in thinking, and the doctor finds changes on a brain and nerve exam. The main tests are brain scans, especially an MRI, and sometimes a CT scan, which can show a growth in the membranes covering the upper part of the brain. In many cases, the final diagnosis is confirmed by looking at a sample of the growth under a microscope after surgery or a biopsy, although some people are diagnosed based on the scan alone if the picture is very typical.
Stages of Supratentorial meningioma
Supratentorial meningioma does not have defined progression stages. This is because it is usually described by where the tumor is, how fast it appears to be growing, and what it looks like under the microscope, rather than by a step-by-step pattern that everyone moves through over time. Doctors usually start with a conversation about symptoms such as headaches, seizures, weakness, or changes in vision or thinking, including the early symptoms of supratentorial meningioma. Imaging tests, especially MRI and sometimes CT scans, are then used to diagnose and monitor the tumor, and surgery or a biopsy may confirm the exact type and grade.
Outlook and prognosis
The outlook for supratentorial meningioma is often favorable, especially when the tumor is benign, small, and can be completely removed surgically. Prognosis depends mainly on tumor grade, size, location near critical brain structures, and how much of the tumor can be safely resected; World Health Organization grade 1 tumors usually have long-term survival rates that are excellent, while grade 2 and grade 3 tumors carry higher risks of recurrence and shorter survival. Even after successful treatment, some people need long-term MRI surveillance because these tumors can recur years later. Symptoms such as seizures, weakness, or cognitive changes may improve after treatment, but some neurologic deficits can persist if the tumor or surgery affects nearby brain tissue. Mortality is generally low for benign supratentorial meningioma, but the risk rises with older age, serious medical comorbidities, large or invasive tumors, and higher-grade disease. Overall, many patients live for years or decades after diagnosis, particularly when the meningioma is completely removed and remains low grade.
Long-term effects
For many people, the long-term effects of supratentorial meningioma depend on where the tumor sits in the upper part of the brain, how large it is, and whether it has been fully treated. Some people do very well for years, while others live with lasting changes that affect work, driving, memory, or independence. Long-term effects vary widely, and they can come from the tumor itself or from surgery, radiation, or repeated treatment over time.
Seizures can remain a long-term issue, especially when supratentorial meningioma affects the brain tissue around the tumor. Even after treatment, some people still need ongoing monitoring because seizures may return months or years later.
Memory, attention, planning, or word-finding problems can linger, particularly if the tumor or treatment affects the frontal or temporal areas of the brain. In daily life, this may feel like losing track of conversations, struggling to multitask, or taking longer to organize simple tasks.
Some people are left with lasting weakness, clumsiness, numbness, or balance problems if nearby movement or sensation pathways were affected. These changes may be mild, or they can make walking, using one hand, or managing stairs harder over time.
If the tumor involves language areas, long-term trouble with speaking, understanding words, reading, or writing can persist after treatment. For some, this means conversations feel slower and finding the right word does not come as easily as before.
How is it to live with Supratentorial meningioma?
Living with a supratentorial meningioma can feel very different from one person to the next: some people have no symptoms for years and only learn about it after a scan, while others live with headaches, seizures, fatigue, trouble concentrating, or changes in mood, vision, or weakness that can affect work, driving, and everyday routines. For many, the hardest part is the uncertainty, because even a slow-growing tumor in this part of the brain can press on nearby areas and change how you think, feel, or function. The people around you may also feel the impact, especially if they help with appointments, medication, transportation, or seizure safety, but with monitoring, treatment when needed, and practical support, many living with supratentorial meningioma are able to keep much of their daily life and independence.
Treatment and drugs
Treatment for supratentorial meningioma depends on where the tumor sits in the upper part of the brain, how fast it is growing, and whether it is causing problems such as headaches, seizures, weakness, or changes in vision or thinking. Many people with supratentorial meningioma are treated with surgery to remove as much of the tumor as is safely possible, while others may be monitored with regular brain scans if the tumor is small, slow-growing, and not causing symptoms. Radiation treatment can be used after surgery or instead of surgery when the tumor is hard to reach or comes back. Doctors may also prescribe medicines to control symptoms, such as drugs to prevent seizures or steroids to reduce swelling around the tumor. Not every treatment works the same way for every person, so the best plan is usually tailored to the tumor’s size and location, your age and overall health, and how symptoms affect daily life.
Can you cure Supratentorial meningioma?
Sometimes, yes. Many supratentorial meningiomas, which are tumors in the lining around the upper part of the brain, can be cured if surgery removes them completely, especially when they are slow-growing and not cancerous. But some cannot be taken out safely or may come back, so treatment may also include close monitoring and radiation to control the tumor and help with symptoms.
Non-drug treatment
Daily life with a supratentorial meningioma can vary a lot. Some people feel well and only need careful follow-up, while others may need treatment because of headaches, seizures, weakness, or changes in thinking, speech, or vision. Beyond prescriptions, supportive therapies can help with symptoms and recovery, especially after a procedure or radiation. The best plan depends on the tumor’s size, location, growth rate, and whether it is causing pressure on nearby brain tissue.
Small or slow-growing supratentorial meningioma may be watched with regular MRI scans and checkups instead of being treated right away. This can be a good option when symptoms are mild, the tumor is found by chance, or treatment risks may outweigh the benefits for now.
Surgery is often the main non-drug treatment when the tumor is causing symptoms or showing clear growth. The goal is to remove as much of the tumor as is safely possible while protecting nearby brain areas that control movement, language, vision, or memory.
Radiation can be used after surgery if some tumor remains, or as a non-surgical treatment for supratentorial meningioma when an operation is not a good fit. It aims focused energy at the tumor to slow or stop growth while limiting exposure to healthy brain tissue.
Stereotactic radiosurgery is a very precise form of radiation that treats the tumor in one session or a few sessions without an incision. It is often used for smaller tumors, hard-to-reach areas, or regrowth after earlier treatment.
Your genes may have an impact on how drugs work for you
For people with supratentorial meningioma, treatment is usually centered on surgery and sometimes radiation, so gene-based drug matching is not a routine part of care for the tumor itself. Still, inherited differences in how the body handles medicines can affect drugs that may be used around treatment, such as anti-seizure medicines, pain medicines, or drugs to help with swelling, which can mean one person gets good control while another has more side effects or needs a different dose. This area is called pharmacogenomics, but for this condition it is usually a smaller part of treatment than the tumor’s size, location, and how fast it is growing.
Pharmacological treatments
For supratentorial meningioma, medicines are usually used to control symptoms or swelling rather than cure the tumor itself. Medication can feel like a big step, but these drugs can make day-to-day life easier while someone is being evaluated for surgery, recovering afterward, or having radiation. In recurrent or hard-to-treat supratentorial meningioma, a few systemic drugs may be tried, although no standard medicine works for everyone.
Dexamethasone is a steroid often used to quickly reduce brain swelling around a supratentorial meningioma. This can ease headaches, nausea, weakness, or trouble thinking, especially before or after surgery.
Levetiracetam is a common anti-seizure medicine for people with supratentorial meningioma who have had seizures. Other seizure drugs such as lacosamide or lamotrigine may be used if needed, because not everyone responds to the same medication in the same way.
Some people need older anti-seizure medicines such as valproate, carbamazepine, or phenytoin, especially if seizures are hard to control. Doctors choose among them based on side effects, other health conditions, and how they may interact with steroids or cancer care.
Acetaminophen and, in some cases, stronger prescription pain medicines may help with headaches or pain after treatment. These drugs do not treat the tumor itself, but they can be an important part of medications for supratentorial meningioma when symptoms interfere with sleep or daily activities.
Genetic influences
When a supratentorial meningioma is found, many people want to know whether it happened by chance or whether it may affect other relatives. Most supratentorial meningiomas are not inherited; they develop from gene changes that arise in the tumor cells over time rather than from a gene passed down through a family. It’s natural to ask whether family history plays a role, and it can in a small number of cases, especially in people with neurofibromatosis type 2 and a few other rare inherited syndromes. Researchers have found several genes involved in meningiomas, with NF2 being one of the best known, but these changes are often limited to the tumor itself and do not automatically mean close relatives are at the same risk. This is why the genetic causes of supratentorial meningioma are usually described as a mix of acquired tumor changes and, less often, inherited risk. If someone is diagnosed at a younger age, has more than one meningioma, or has a family history of related tumors, a doctor may suggest genetic counseling or testing.
Is Supratentorial meningioma genetic?
Genetics usually play a limited role in supratentorial meningioma, and most cases are not clearly inherited. Some genetic changes in the tumor itself can affect growth and recurrence risk, while inherited risk is mainly linked to rare conditions such as NF2.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a common and normal part of being human, and they are found across the general population. Most do not have a direct effect on health and simply reflect natural differences among people. For many genes, having a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For many people with supratentorial meningioma, treatment decisions are shaped less by inherited traits and more by gene changes inside the tumor itself. After surgery, lab testing of the tumor tissue may find changes such as NF2, AKT1, or SMO, which can help doctors estimate how likely the tumor is to grow back and how closely it should be monitored. Not every difference in response is genetic, but some findings, including TERT promoter changes or loss of CDKN2A/B, are linked with a more aggressive course and may support earlier radiation or closer follow-up. Drug treatment for supratentorial meningioma is still limited, and there is no standard targeted medicine that works for everyone. Still, tumor genetics can help identify people with supratentorial meningioma who may be eligible for targeted treatments or clinical trials, especially if the tumor returns or cannot be fully removed. If you are wondering how genetics affect treatment for supratentorial meningioma, their biggest role today is in guiding prognosis, follow-up, and trial options rather than choosing a routine drug used for all patients.
Interactions with other conditions
A supratentorial meningioma can be especially disruptive when someone is already living with another brain or nerve condition, because headaches, seizures, weakness, vision changes, or memory problems may overlap and feel more intense. Having more than one diagnosis can make symptoms feel harder to untangle. For example, people with epilepsy may notice more seizures, while those with a past stroke, migraine, or memory disorder may find that early symptoms of supratentorial meningioma are easy to mistake for their usual condition. Some inherited conditions, especially neurofibromatosis type 2, can also occur alongside supratentorial meningioma and raise the chance of having more than one tumor in the nervous system. Other health problems, such as blood clotting disorders, heart disease, or uncontrolled diabetes, do not usually cause the tumor but can affect how safely surgery, radiation, and recovery are managed. Because of this, care often works best when the neurosurgeon, neurologist, and primary care doctor look at the full picture together.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Supratentorial meningioma?
Because a supratentorial meningioma can cause headaches, seizures, weakness, trouble speaking, vision changes, or changes in thinking and behavior, it can sometimes look like other brain tumors, a stroke, migraine, or a seizure disorder. Less often, bleeding in the brain or a brain infection can cause similar problems, which is why brain scans and a careful exam are usually needed to tell the difference.
History
People living with supratentorial meningioma are often dealing with symptoms that can creep in slowly, like more frequent headaches, changes in vision, or trouble concentrating at work or at home, long before they ever hear the name of the condition. The broader tumor type, meningioma, has been recognized for a long time, but doctors did not always separate tumors by their exact location in the brain the way they do now.
Since the earliest days of medicine, efforts have been made to understand growths inside the skull, although early doctors had no brain scans and had to rely on symptoms and findings after surgery or at autopsy. In the 18th and 19th centuries, physicians began describing these tumors more carefully and noticed that some grew from the coverings around the brain rather than from brain tissue itself. That was an important step, because it helped explain why many meningiomas tend to grow slowly and press on nearby areas instead of spreading through the brain in the way some other tumors do.
As medical science evolved, surgeons and pathologists became better at telling one brain tumor from another. By the late 19th and early 20th centuries, meningioma was established as a distinct diagnosis, and over time doctors learned that tumors in the upper part of the brain, the supratentorial region, could cause different problems depending on where they sat. For many, this can mean seizures, personality or memory changes, weakness, or speech problems if the tumor presses on nearby brain tissue.
The history of supratentorial meningioma changed dramatically once imaging arrived. First with X-rays used in limited ways, and later with CT and MRI scans, doctors could finally see these tumors in living patients instead of piecing the story together afterward. This made earlier diagnosis possible and helped surgeons plan safer operations. In recent decades, awareness has grown around the fact that not all meningiomas behave the same way: some remain stable for years, while others need surgery, radiation, or close follow-up. Researchers later identified that meningiomas can have genetic changes, but the biggest historical shift for patients has been practical: clearer diagnosis, better treatment planning, and a much better understanding of what symptoms mean in everyday life.